Related Experiment Video

Updated: Apr 25, 2026

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates
13:55

Sexual Transmission of American Trypanosomes from Males and Females to Naive Mates

Published on: January 27, 2019

14.4K

The role of haptoglobin genotypes in Chagas disease

Ninomar Mundaray Fernández1, Mercedes Fernández-Mestre1

  • 1Laboratorio de Fisiopatología, Centro de Medicina Experimental "Miguel Layrisse", Instituto Venezolano de Investigaciones Científicas, Kilómetro 11 Carretera Panamericana, Apartado 21827, Caracas 1020A, Venezuela.

Disease Markers
|August 23, 2014
PubMed

Insights

Haptoglobin (HP) gene variations influence Chagas disease progression. The HP1-1 genotype may protect against chronic Chagas disease, while HP2-2 might increase susceptibility and cardiac issues.

Area of Science:

  • Genetics
  • Immunology
  • Infectious Diseases

Background:

  • Chagas disease, caused by T. cruzi infection, is increasing globally.
  • Host genetic factors play a critical role in disease development and severity.
  • Haptoglobin (HP) is a protein involved in hemoglobin binding and antioxidant functions.

Purpose of the Study:

  • To investigate the association between haptoglobin (HP) gene polymorphisms and chronic Chagas disease.
  • To explore the potential role of HP genotypes in disease susceptibility and cardiac manifestations.

Main Methods:

  • Genotyping of haptoglobin (HP) gene in patients with chronic Chagas disease.
  • Analysis of the frequency of different HP genotypes (e.g., HP1-1, HP2-2).
  • Correlation analysis between HP genotypes and clinical outcomes, including cardiac function.

Main Results:

  • The HP1-1 genotype may offer protection against T. cruzi infection and chronic Chagas disease development.
  • The HP2-2 genotype is associated with increased susceptibility to chronic Chagas disease.
  • HP2-2 genotype correlates with slower hemoglobin-haptoglobin complex metabolism, reduced antioxidant activity, and heightened inflammation, potentially leading to cardiac damage.

Conclusions:

  • Haptoglobin (HP) gene polymorphism is a significant factor influencing the clinical course of Chagas disease.
  • HP genotypes may impact disease prognosis, particularly concerning cardiac manifestations.
  • Understanding HP polymorphism offers insights into host-pathogen interactions in T. cruzi infection.

More Related Videos

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model09:23

Parasite Induced Genetically Driven Autoimmune Chagas Heart Disease in the Chicken Model

Published on: July 29, 2012

17.5K
A Multi-detection Assay for Malaria Transmitting Mosquitoes09:00

A Multi-detection Assay for Malaria Transmitting Mosquitoes

Published on: February 28, 2015

12.7K

Related Concept Videos

Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
32.5K
Genetic Variation01:25

Genetic Variation

Genetic variation is the diversity in DNA sequences found among individuals of the same species. This diversity is crucial for a species' survival because it helps organisms adapt to environmental changes. Genetic variation begins with fertilization, where an egg and sperm cell merge. Each of these cells carries 23 chromosomes, up to 46 in the fertilized egg. Chromosomes are long DNA strands that contain genes, the basic units of heredity.
Genes exist in different versions called alleles,...
1.6K
Genetic Lingo01:11

Genetic Lingo

Overview
84.2K
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
189
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
119
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
156